Log in
Donate

Clinical Trial: NRG GU010

NRG GU010

Status: Open

NCT#05050084

Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification And Intensification Clinical Trial Evaluation (GUIDANCE)

Eligible for screening study DCP 001

GU010 intensification cohort (Groups 3 and 4) will close to accrual at 5 PM ET November 22, 2024 

GU010 De-intensification cohort (Group 1 and 2) will remain open to patient accrual.

View All Clinical Trials
The Montana Cancer Consortium (MCC) is an independent nonprofit organization whose mission is to bring state-of-the-art cancer care to Montana, Idaho and Wyoming through National Cancer Institute (NCI) sponsored clinical research.

Navigation

About Us

Contact Us

Copyright © Montana Cancer Consortium | All rights reserved